ESC 365 - Effects of once-weekly semaglutide on major adverse cardiovascular events in patients with type 2 diabetes and polyvascular disease: a post hoc analysis of the SUSTAIN 6 trial

ESC Professional Premium Access

Effects of once-weekly semaglutide on major adverse cardiovascular events in patients with type 2 diabetes and polyvascular disease: a post hoc analysis of the SUSTAIN 6 trial

Session: Diabetes and the heart

Topic: Pharmacotherapy

Speaker: Doctor O. Kobo (Hadera, IL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Ofer Kobo

Hillel Yaffe Medical Center, Hadera (Israel)

0 follower

5 more presentations in this session

ZNF259 rs964184 genetic variant is associated with metabolic syndrome in a Portuguese population

Speaker: Doctor D. Sa (Funchal, PT)

Effect of exercise in incident atrial fibrillation among diabetes mellitus with different diabetes duration

Speaker: Miss J. Choi (Seoul, KR)

Metabolic disorders predict future impairment of kidney function in the Japanese general population

Speaker: Doctor F. Kin (Hamamatsu, JP)

Outcomes of diabetic patients with acute coronary syndromes treated with aspirin in primary prevention

Speaker: Doctor H. Costa (Faro, PT)

Myocardial performance index improves prediction of major adverse cardiovascular events and heart failure in type 1 and type 2 diabetes without known heart disease: Thousand&1 and Thousand&2 study

Speaker: Doctor H. Bahrami (Copenhagen, DK)

Access the full session

Diabetes and the heart

Speakers: Doctor O. Kobo, Doctor D. Sa, Miss J. Choi, Doctor F. Kin, Doctor H. Costa...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources